chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt stated that she had fatigue, she had severe chills, sharp muscle pains, loss of appetite.  She said she had sore muscle around her eyeballs, that it hurts to move her eyes.  She also had a bad taste in her mouth.  She has not contacted her PCP at this time since her symptoms seem to be improving.
First day there was pain in her right arm at the injection site. Second day she had pain around most of her upper arm and the injection site. Third day she had a non-itchy rash around the injection site and around her upper arm.
High blood sugar that went from 120 to 160; This spontaneous case was reported by a consumer and describes the occurrence of   in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025002X) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 05-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Jan-2021, Blood glucose increased: 120-160 (High) Blood sugar that went from 120 to 160.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The event was consistent with increased risk of complications associated with elderly age of patient. Company assessed the events to be unlikely related to company product.; Reporter's Comments: The event was consistent with increased risk of complications associated with elderly age of patient. Company assessed the events to be unlikely related to company product.
Information has been received from a registered nurse concerning a patient who on 6/19/96 was vaccinated with a dose of varicella virus vaccine live (lot # 609287/0393B). Subsequently, on 12/11/02, the patient developed chicken pox. The patient was seen in the office. The reporter also indicated that 30 other patients were vaccinated with varicella virus vaccine live and developed chicken pox (WAES0409USA00600, 0409USA01045, 0409USA01046, 0409USA01047, 0409USA01048, 0409USA01049, 0409USA01050, 0409USA01051, 0409USA01052, 0409USA01053, 0409USA01054, 0409USA01055, 0409USA01056, 0409USA01057, 0409USA01058, 0409USA01059, 0409USA01060, 0409USA01061, 0409USA01062, 0409USA01063, 0409USA01064, 0409USA01065, 0409USA01066, 0409USA01067, 0409USA01068, 0409USA01069, 0409USA01070, 0409USA01072, 0409USA01073, and 0409USA01074). No further information is expected.
Worst vaccine I got for pain; This case was reported by a nurse via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain. On an unknown date, the outcome of the pain was unknown.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by patient who was also a nurse. The age at vaccination was not reported. As a nurse the reporter treated people with shingles, and they stated it was extremely painful.  It was worst vaccine the patient got for pain but was not sure minuscule amount compared to the virus.  They asked to get vaccinated.
I started with A. My throat tingling/itching  B. My left ear started to ache  C. My head started to hurt bad  D.  I felt a burning  sensation  in my face E.  While all of this is happening my left earlobe was tingling  The next morning I had shingles on my left earlobe
Hospitalization 1/29/2022-2/10/2022 for acute respiratory failure; COVID-19 pneumonia. Treated with baricitinib, Remdesivir, dexamethasone, zinc 50mg daily, vitamin D3 50mcg daily and vitamin C 1,000mg daily.
Seriousness criteria: other medically significant (OMIC). Initial report received on 7/27/06 from a health care professional. A male pt age not reported, date of birth 1/18/2001, was vaccinated with IPOL, Daptacel, and MMR vaccine on an unknown date, The lot numbers, routes and sites of administration were not reported. 20 minutes post vaccination, the child developed a generalized raised red rash, facial swelling and difficulty swallowing. Per the reporter, these were considered to be anaphylactic signs and symptoms. The child was seen in an ER and treated, but no further details were provided. An allergist determined that the pt was allergic to gelatin. The pt recovered from the events.
At around 7 pm on 12/31/20, I started developing chills, neck stiffness, body aches, shivering, surface veins on the injection site became more prominent.  Sometimes the next day,  I noticed rashes developed on both sides of neck,  started near the angle of mandible and travelled down towards the clavicles.
After 3rd Anthrax shot,left arm swelled,turned red, and developed a rash.  By third day arm was twice its usual size and had lost feeling in left hand.  Pt. had smaller reactions to shots 1 and 2. Sx lasted 1 wk.Tx w/ antibiotic.
This spontaneous report was received from a medical assistance referring to a female patient of unknown age. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported. On an unknown date, the patient was vaccinated with her second VAQTA (50U/1.0 ml PF SYR)(route, dose, frequency, anatomical location, lot # and expiration date were unknown) with lot # N020950 and expiration date 17-OCT-2018 one week before the recommended schedule in the prescribing information,for prophylaxis. No adverse effects were reported in the patient.
This is a spontaneous report from a contactable reporter (consumer or other non HCP). The reporter is the patient. A 68-year-old patient received bnt162b2 (BNT162B2), administered in left arm, administration date 04Oct2021 at 19:00 (Lot number: 30155BA) at the age of 68 years as dose 3 (booster), single for COVID-19 immunisation. Relevant medical history included: "Penicillin allergy" (unspecified if ongoing), notes: Known allergies: Penicillin and "Bee sting hypersensitivity" (unspecified if ongoing), notes: Known allergies: Bees. The patient had received concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot Number: 6203, Anatomical Location: Left arm), administration date: 27Feb2021, when the patient was 67 years old, for COVID-19 immunisation and Bnt162b2 (DOSE 2, SINGLE, Lot Number: 7534, Anatomical Location: Left arm), administration date: 20Mar2021, when the patient was 67 years old, for COVID-19 immunisation. The following information was reported: IMMUNISATION (non-serious) with onset 04Oct2021 at 19:00, outcome "unknown", described as "Dose received: 3"; URTICARIA (non-serious) with onset 11Oct2021, outcome "not recovered", described as "Went swimming in a lake with cold water, immediately welted up with red hives all over my body up to the water line"; PRURITUS (non-serious) with onset 11Oct2021, outcome "not recovered", and all described as "After that, Ive had the same skin reaction to cold weather - my skin breaks out in hives, itches, burns and turns red"; BURNING SENSATION (non-serious) with onset 11Oct2021, outcome "not recovered", and all described as "After that, Ive had the same skin reaction to cold weather - my skin breaks out in hives, itches, burns and turns red"; ERYTHEMA (non-serious) with onset 11Oct2021, outcome "not recovered", and all described as "After that, Ive had the same skin reaction to cold weather - my skin breaks out in hives, itches, burns and turns red"; COLD URTICARIA (non-serious) with onset 11Oct2021, outcome "not recovered", described as "Doctors office felt it was cold induced urticaria in a phone consult.". The events "Went swimming in a lake with cold water, immediately welted up with red hives all over my body up to the water line.", "After that, Ive had the same skin reaction to cold weather - my skin breaks out in hives, itches, burns and turns red." and "Doctors office felt it was cold induced urticaria in a phone consult." were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of urticaria, pruritus, burning sensation, erythema and cold urticaria. Additional information: The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19.
cough, sore throat, headaches, body aches, fever, starting on 9/18/21. Husband tested positive on 9/17/21
pt recv vax 5AUG97 & 29SEP97 pt dx w/acute cerebellar ataxia;pt hosp for 3 days;29SEP97 lab eval revealed nl blood chem x/high serum glucose (154 & 115), high serum cholesterol (214), high ESR (19);CXR revealed minimal peribronchial cuffing
itchy red chest; slept most of the day away; headache; dehydrated; nausea; sore arm/arm extremely sore; tired/ whole body exhausted; This is a spontaneous report from a contactable consumer. This 27-year-old contactable non-pregnant female consumer (patient) reported that she received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: Csn20451972883, Expiry Date: not reported), via an unspecified route of administration, administered in left arm on 24Apr2021 at 10:45 (at the age of 27 years) as dose 2, single for covid-19 immunisation. Medical history included exercise induced asthma. Concomitant medication(s) included ethinylestradiol, norgestimate (SPRINTEC), daily taken for an unspecified indication, start and stop date were not reported; cetirizine, daily taken for an unspecified indication, start and stop date were not reported. The patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: Csn20451497957, Expiry Date: not reported), via an unspecified route of administration, administered in left arm on 03Apr2021 at 10:00 (at the age of 27 years) as dose 1, single for covid-19 immunisation. No other vaccine was received in four vaccine. No Covid prior vaccination and no Covid tested post vaccination. On 24Apr2021 at 06:30 AM, (1st day) sore arm, tired. On 25Apr2021 (2nd day), whole body exhausted, arm extremely sore, dehydrated, slept most of the day away, headache, nausea. On 26Apr2021 (3rd day), tired, arm sore, itchy red chest, nausea, a little tired. No treatment received. The outcome of events were recovered.  Follow-up attempts are completed. No further information is expected.
patient received a vaccine and was informed to wait 15 minutes. While I was administering the vaccine to someone else, we heard a crash, when I jumped up, I see  him on the floor. I told a tech to call 911 and the manager. A customer called 911 for me on her cell phone. The patient asked for a bottle of water which we quickly got for him. He was delirious and sweating for a while but after drinking the water appeared to recover. Rescue came but I think the patient was ok by the time they arrived. He had gotten help up from off of the floor and to the chairs. I asked him where he was going because he was supposed to wait 15 minutes and he replied that he was going to get something to drink
Sore arm; A spontaneous report () was received from a consumer concerning her husband, a 77-year-old male patient who received Moderna (mRNA-1273) vaccine and experienced a sore arm..  The patient's medical history was not provided. Concomitant product use was unknown by the reporter.  On 27 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (Batch number: 025L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 27 Jan 2021, prior to the onset of symptoms, the patient received their second of two planned doses of mRNA-1273 (Batch number: unknown) via unknown route in the left arm for prophylaxis of COVID-19 infection.  On the same day 27 Jan 2021, the patient experienced a sore arm.  Treatment information was unknown.  The patient received both scheduled doses of mRNA-1273 prior to the event(s); therefore, action taken with the drug in response to the event(s) is not applicable.  The outcome of the event, a sore arm was considered resolved at the time of this report.
Put off the second one for 3 years; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (1st dose received on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced drug dose administration interval too long (Verbatim: Put off the second one for 3 years).  The outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK Receipt date: 05-MAR-2023 This case was reported by a patient via interactive digital media. The patient received two shots, and stated that, he/she put off the second dose for 3 years until she/he was reminded how bad it was to get it. The follow-up could not be possible as no contact details were available. The patient received 2nd dose of Shingles vaccine later than the recommended interval, which led to lengthening of the vaccine schedule.
Moderna 0.5ml IM administered instead of 0.25ml for booster dose.
Diarrhea; Pain in arm; Low grade fever of 99.2F; Chills; Body aches; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHEA (Diarrhea ), PAIN IN EXTREMITY (Pain in arm), PYREXIA (Low grade fever of 99.2F), CHILLS (Chills) and MYALGIA (Body aches) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included VITAMIN C [ASCORBIC ACID], LEVOTHYROXINE SODIUM (SYNTHROID), ROSUVASTATIN CALCIUM (CRESTOR), OMEPRAZOLE and MELOXICAM for an unknown indication.    On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021, the patient experienced DIARRHEA (Diarrhea ), PAIN IN EXTREMITY (Pain in arm), PYREXIA (Low grade fever of 99.2F), CHILLS (Chills), MYALGIA (Body aches) and NAUSEA (Nausea). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) ongoing since an unknown date at a dose of UNK, prn. At the time of the report, DIARRHEA (Diarrhea ), PAIN IN EXTREMITY (Pain in arm) and PYREXIA (Low grade fever of 99.2F) outcome was unknown and CHILLS (Chills), MYALGIA (Body aches) and NAUSEA (Nausea) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-May-2021, Body temperature: 99.2 (High) 99.2 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact  No treatment information was reported.
Information has been received from a pharmacist (local reference ID # US12-036670) concerning a female healthcare professional with a history of chickenpox 3 times in her childhood and a history of shingles in her adulthood ("a time when she had outbreak every 3-4 months"). On an unknown date, the reporter broke out in a case of shingles within 48 hours of administering ZOSTAVAX. She sought a medical attention immediately and received VALTREX. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
Employee calling to report a reaction after receiving a COVID-19 vaccine.  Vaccine Name -  Pfizer Vaccine Date - ?  9/27/2021 Is this your first or second dose- 3rd (booster) Date of symptom onset - ? 9/27/2021 Symptoms - ? body aches, headache, and nausea Last day of work and shift - ? NA Home remedies-NA Any improvement-NA Recommendation- Advised employee to take Tylenol or Ibuprofen per pack instructions for pain. Employee voiced understanding Employee of information ? Yes  Employee voiced any concerns ? No  Employee?s questions answered to employee?s satisfaction -Yes
pt states he developed symptoms of covid.  His body is itchy feeling all over his body on the inside. His muscles felt heavy, he felt hot and was sweating with no fever. His heart beating about 125 bpm.  On 4/30/21 he went to ER.  EKG was normal.  Blood test  results showed TSH low and T3 is high.  He repeated test 4 days later and had the same results. These test were normal before taking the vax.  He was discharged to see a endocrinologist on 5/26/2021.  Pt still has the itchy sensation, his eyes burn, still feeling extremely tired and feels like he dying.
COVID vaccine was given to patient under 18 years old.  Parent states there were no adverse effects.
Arm where shot was administered feels like I'm being stung by a bee but nothing is there I feel like Im going crazy I have this happen throughout the day when I use my arm it gets worse.
This spontaneous report as received from an office manager refers to a 2-year-old male patient. His medical history, drug reactions/allergies, concurrent conditions and concomitant medications were not reported. On 29-MAR-2018, the patient was vaccinated with a dose of VARIVAX (dose, route and site of administration, lot number and expiration date were not reported) that was reconstituted with an improperly stored sterile diluent (dose, route and site of administration were not reported, lot # M009799, expiration date: 11-SEP-2018). The sterile diluent was stored in temperature below 32 Fahrenheit degrees (F) (-11 F) for 120 hours. There was a previous temperature excursion of 32 F up to 35 F (34.5 F) for 45 minutes. Temperature excursion occurred as a result of a reading from a Digital Data Logger. It was confirmed that VARIVAX had no temperature excursion prior to being administered. No adverse effects were reported. This is one of several reports received from the same source. Sender's Comments: US-009507513-1804USA013048: US-009507513-1804USA013049.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 15Sep2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 48 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Prehypertension" (unspecified if ongoing); "GERD" (unspecified if ongoing); "Known allergies: Penicillin" (unspecified if ongoing), notes: Known allergies: Penicillin. Concomitant medication(s) included: CHLORTHALIDONE; PANTOPRAZOLE, start date: 15Aug2022. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Anti-viral details: Product COVID 19 Treatment; Brand Paxlovid; Treatment start date was on 21Nov2022 and treatment stopped on 26Nov2022; Indication: Treatment of COVID-19.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Case number PHEH2014US025052, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 07 year old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN, (batch number: 145701) intramuscularly at a dose of 0.5 ml on 17 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion.
I was about 6.5 weeks pregnant and experienced medium to heavy bleeding.  I went to the emergency room, and they indicated that the fetus was fine.  The next day I would bleed if I was moving around so I stayed in bed for two days.  I have had three miscarriages prior to this pregnancy, but i did not have this bleeding in any of them? they seem to have been due to a septum which has now been removed.
Patient reports she received vaccine in the evening of 10/28 and by 11:30 PM patient was cold and shaking so hard from chills that she fell off her chair. She experienced nausea and vomiting that night as well. Stopped vomiting on the following day but was still shaking. Pharmacist spoke with patient on the phone 10/30 and patient stated that she was feeling better. Pharmacist recommended seeking medical attention if symptoms worsen.
Swelling extended down the wrist; Tired; Little bit of headache; Red; Paretic; Itchy; Induration/not painful but there was induration; Arm was swollen at injection site; Arm was sore/arm was sore, similar as previous vaccination; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (Arm was sore/arm was sore, similar as previous vaccination), ERYTHEMA (Red), PARESIS (Paretic), PRURITUS (Itchy) and INDURATION (Induration/not painful but there was induration) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Immunosuppression (Immune suppressive disease). Concomitant products included ESOMEPRAZOLE SODIUM (NEXIUM [ESOMEPRAZOLE SODIUM]) and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 16-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Aug-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore/arm was sore, similar as previous vaccination). On 18-Aug-2021, the patient experienced ERYTHEMA (Red), PARESIS (Paretic), PRURITUS (Itchy), INDURATION (Induration/not painful but there was induration), VACCINATION SITE SWELLING (Arm was swollen at injection site), FATIGUE (Tired) and HEADACHE (Little bit of headache). On 20-Aug-2021, the patient experienced JOINT SWELLING (Swelling extended down the wrist). The patient was treated with HYDROCORTISONE (topical) at a dose of 1.5 %. On 18-Aug-2021, FATIGUE (Tired) and HEADACHE (Little bit of headache) had resolved. At the time of the report, PAIN IN EXTREMITY (Arm was sore/arm was sore, similar as previous vaccination), ERYTHEMA (Red), PARESIS (Paretic), PRURITUS (Itchy) and INDURATION (Induration/not painful but there was induration) outcome was unknown and VACCINATION SITE SWELLING (Arm was swollen at injection site) and JOINT SWELLING (Swelling extended down the wrist) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information also included: Anti histamines   This case was linked to MOD-2021-294494 (Patient Link).
Patient had received 3 doses of RabAvert 2 months earlier in order to work as a vet tech and had no problem. She was exposed to a rabid cat at work and presented for 2 more vaccines. 12 hours post vaccine, she developed fever, aches, myalgia, joint pains lasting 12 hours. No rash/respiratory distress. Serum sickness like reaction reported with 2nd vaccine.